Acro Biomedical (ACBM) Assets Average (2016 - 2026)
Acro Biomedical (ACBM) posted Assets Average of $8873.0 for Q2 2026, down 3.66% on a QoQ basis from $9210.5 in Q4 2025, and down 77.38% year-over-year from $39226.0 in Q2 2025.
Analysis
Acro Biomedical (ACBM) Assets Average (2016 - 2026) Analysis & Trends
Acro Biomedical has reported Assets Average for 11 years, with the latest figure at $8873.0 in Q2 2026.
- On a quarterly basis, Assets Average fell 77.38% year-over-year to $8873.0 in Q2 2026; TTM through Jun 2026 was $8873.0, a 77.38% decrease from a year earlier, with the FY2025 full-year figure at $23036.0, down 49.05% from the prior year.
- Assets Average was $8873.0 for Q2 2026 at Acro Biomedical, down from $9210.5 in the prior quarter.
- The five-year high for Assets Average was $744835.5 in Q1 2022, with the low at $8873.0 in Q2 2026.
- Average Assets Average over 5 years is $273446.4, with a median of $48036.5 recorded in 2024.
- The sharpest annual moves came in 2022 and 2023: Assets Average decreased 1.29% in 2022, then tumbled 94.18% in 2023.
- Over 5 years, Assets Average stood at $665567.0 in 2022, then sank by 94.18% to $38743.0 in 2023, then fell by 8.82% to $35325.0 in 2024, then slumped by 73.93% to $9210.5 in 2025, then retreated by 3.66% to $8873.0 in 2026.
- The last three Assets Average figures came in at $8873.0 (Q2 2026), $9210.5 (Q4 2025), and $28800.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn | 16.70 Bn |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn | 26.79 Bn |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn | 17.87 Bn |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn | 5.11 Bn |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - | 3.49 Bn |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn | 7.80 Bn |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn | 2.87 Bn |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn | 3.53 Bn |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | 4.64 Mn |
| 10 | Acro Biomedical | 1.80 Mn | 1.80 Mn | - | 8,873.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8,873.00 |
| Dec 31, 2025 | 9,210.50 |
| Sep 30, 2025 | 28,800.00 |
| Jun 30, 2025 | 39,226.00 |
| Mar 31, 2025 | 28,574.50 |
| Dec 31, 2024 | 35,325.00 |
| Sep 30, 2024 | 41,978.50 |
| Jun 30, 2024 | 48,036.50 |
| Mar 31, 2024 | 54,625.50 |
| Dec 31, 2023 | 38,743.00 |
| Sep 30, 2023 | 279,087.50 |
| Jun 30, 2023 | 598,042.50 |
| Mar 31, 2023 | 672,211.50 |
| Dec 31, 2022 | 665,567.00 |
| Sep 30, 2022 | 656,489.50 |
| Jun 30, 2022 | 698,962.50 |
| Mar 31, 2022 | 744,835.50 |
| Dec 31, 2021 | 695,452.50 |
| Sep 30, 2021 | 665,096.50 |
| Jun 30, 2021 | 819,619.50 |